NO20063261L - Selektive peroksisome proliferatoraktiviterte reseptormodulatorer - Google Patents
Selektive peroksisome proliferatoraktiviterte reseptormodulatorerInfo
- Publication number
- NO20063261L NO20063261L NO20063261A NO20063261A NO20063261L NO 20063261 L NO20063261 L NO 20063261L NO 20063261 A NO20063261 A NO 20063261A NO 20063261 A NO20063261 A NO 20063261A NO 20063261 L NO20063261 L NO 20063261L
- Authority
- NO
- Norway
- Prior art keywords
- activated receptor
- peroxisome proliferator
- receptor modulators
- syndrome
- compound
- Prior art date
Links
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 title abstract 3
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000011580 syndromic disease Diseases 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 201000001421 hyperglycemia Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Liquid Crystal Substances (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03380288 | 2003-12-15 | ||
| US55063604P | 2004-03-05 | 2004-03-05 | |
| PCT/US2004/038232 WO2005061441A1 (en) | 2003-12-15 | 2004-12-08 | Selective peroxisome proliferator activated receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20063261L true NO20063261L (no) | 2006-09-06 |
Family
ID=34712592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20063261A NO20063261L (no) | 2003-12-15 | 2006-07-13 | Selektive peroksisome proliferatoraktiviterte reseptormodulatorer |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7321056B2 (pl) |
| EP (1) | EP1697306B1 (pl) |
| JP (1) | JP2007516267A (pl) |
| KR (1) | KR100806004B1 (pl) |
| CN (1) | CN1886364A (pl) |
| AT (1) | ATE368026T1 (pl) |
| AU (1) | AU2004303793A1 (pl) |
| BR (1) | BRPI0417401A (pl) |
| CA (1) | CA2549008A1 (pl) |
| CY (1) | CY1106846T1 (pl) |
| DE (1) | DE602004007825T2 (pl) |
| DK (1) | DK1697306T3 (pl) |
| EA (1) | EA009023B1 (pl) |
| EC (1) | ECSP066639A (pl) |
| ES (1) | ES2289589T3 (pl) |
| HR (1) | HRP20070422T3 (pl) |
| IL (1) | IL175997A0 (pl) |
| MA (1) | MA28399B1 (pl) |
| MX (1) | MXPA06006829A (pl) |
| NO (1) | NO20063261L (pl) |
| PL (1) | PL1697306T3 (pl) |
| PT (1) | PT1697306E (pl) |
| SI (1) | SI1697306T1 (pl) |
| WO (1) | WO2005061441A1 (pl) |
| ZA (1) | ZA200604834B (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013049621A1 (en) * | 2011-09-29 | 2013-04-04 | The Board Of Regents Of The University Of Oklahoma | Ophthalmic compositions comprising ppar-alpha agonists and methods of production and use thereof |
| CN106310173A (zh) * | 2016-08-24 | 2017-01-11 | 厦门三川利生物科技有限公司 | 含过氧化物酶体增殖物激活受体多维果酸醇及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9604242D0 (en) * | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| WO2000061582A1 (en) * | 1999-04-08 | 2000-10-19 | Sankyo Company, Limited | Substituted fused imidazole derivatives |
| AU2002222552A1 (en) * | 2000-11-29 | 2002-06-11 | Kyorin Pharmaceutical Co. Ltd. | Substituted carboxylic acid derivatives |
| WO2002083616A1 (en) * | 2001-04-10 | 2002-10-24 | Sankyo Company, Limited | α-SUBSTITUTED φ-ARYLFATTY ACID DERIVATIVE |
| SE0104334D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| GB0314079D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| JP2005529975A (ja) * | 2002-06-19 | 2005-10-06 | イーライ・リリー・アンド・カンパニー | アミドリンカーペルオキシソーム増殖因子活性化受容体調節因子 |
-
2004
- 2004-12-08 JP JP2006545654A patent/JP2007516267A/ja active Pending
- 2004-12-08 CA CA002549008A patent/CA2549008A1/en not_active Abandoned
- 2004-12-08 SI SI200430482T patent/SI1697306T1/sl unknown
- 2004-12-08 DK DK04811083T patent/DK1697306T3/da active
- 2004-12-08 US US10/596,256 patent/US7321056B2/en not_active Expired - Fee Related
- 2004-12-08 CN CNA2004800355126A patent/CN1886364A/zh active Pending
- 2004-12-08 PL PL04811083T patent/PL1697306T3/pl unknown
- 2004-12-08 EP EP04811083A patent/EP1697306B1/en not_active Expired - Lifetime
- 2004-12-08 AU AU2004303793A patent/AU2004303793A1/en not_active Abandoned
- 2004-12-08 PT PT04811083T patent/PT1697306E/pt unknown
- 2004-12-08 MX MXPA06006829A patent/MXPA06006829A/es active IP Right Grant
- 2004-12-08 WO PCT/US2004/038232 patent/WO2005061441A1/en not_active Ceased
- 2004-12-08 BR BRPI0417401-1A patent/BRPI0417401A/pt not_active IP Right Cessation
- 2004-12-08 ES ES04811083T patent/ES2289589T3/es not_active Expired - Lifetime
- 2004-12-08 AT AT04811083T patent/ATE368026T1/de not_active IP Right Cessation
- 2004-12-08 HR HR20070422T patent/HRP20070422T3/xx unknown
- 2004-12-08 EA EA200601159A patent/EA009023B1/ru not_active IP Right Cessation
- 2004-12-08 KR KR1020067011758A patent/KR100806004B1/ko not_active Expired - Fee Related
- 2004-12-08 DE DE602004007825T patent/DE602004007825T2/de not_active Expired - Lifetime
-
2006
- 2006-05-29 IL IL175997A patent/IL175997A0/en unknown
- 2006-06-12 ZA ZA200604834A patent/ZA200604834B/en unknown
- 2006-06-14 EC EC2006006639A patent/ECSP066639A/es unknown
- 2006-07-06 MA MA29171A patent/MA28399B1/fr unknown
- 2006-07-13 NO NO20063261A patent/NO20063261L/no not_active Application Discontinuation
-
2007
- 2007-09-05 CY CY20071101149T patent/CY1106846T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL175997A0 (en) | 2006-10-05 |
| KR20060121192A (ko) | 2006-11-28 |
| JP2007516267A (ja) | 2007-06-21 |
| US7321056B2 (en) | 2008-01-22 |
| HRP20070422T3 (en) | 2007-11-30 |
| CA2549008A1 (en) | 2005-07-07 |
| CY1106846T1 (el) | 2012-05-23 |
| CN1886364A (zh) | 2006-12-27 |
| ECSP066639A (es) | 2006-10-25 |
| AU2004303793A1 (en) | 2005-07-07 |
| ES2289589T3 (es) | 2008-02-01 |
| BRPI0417401A (pt) | 2007-05-08 |
| DE602004007825D1 (de) | 2007-09-06 |
| ATE368026T1 (de) | 2007-08-15 |
| DK1697306T3 (da) | 2007-11-12 |
| EA200601159A1 (ru) | 2006-10-27 |
| MA28399B1 (fr) | 2007-01-02 |
| EP1697306A1 (en) | 2006-09-06 |
| SI1697306T1 (sl) | 2008-02-29 |
| US20070066683A1 (en) | 2007-03-22 |
| PL1697306T3 (pl) | 2007-11-30 |
| EP1697306B1 (en) | 2007-07-25 |
| KR100806004B1 (ko) | 2008-02-26 |
| EA009023B1 (ru) | 2007-10-26 |
| MXPA06006829A (es) | 2006-08-23 |
| DE602004007825T2 (de) | 2008-04-17 |
| HK1097406A1 (en) | 2007-06-22 |
| ZA200604834B (en) | 2007-11-28 |
| PT1697306E (pt) | 2007-10-19 |
| WO2005061441A1 (en) | 2005-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE386715T1 (de) | Modulatoren des peroxisomproliferatoraktivierten rezeptors | |
| NO20074117L (no) | Fremgangsmater og sammensetninger for a behandle diabetes, metabolske sykdommer og tilstander | |
| BR0210167A (pt) | Composto, composição farmacêutica, métodos para modular um receptor ativado com proliferador de peroxissoma, para tratar ou prevenir uma doença ou condição e para abaixar a glicose no sangue, e, uso de um composto | |
| SA521431209B1 (ar) | مواد مساعدة لمستقبل الببتيد الشبيه بالجلوكاجون 1 | |
| NO20073831L (no) | Medikamenter for behandling eller forebygging av fibrotiske sykdommer | |
| NO20084874L (no) | Piendinylsubstituerte pyrrolidinoner som hemmere av 11-beta-hydroksysteroiddehydrogenase 1 | |
| NO20076479L (no) | Nye oksadiazolderivater og anvendelse derav som positive allosteriske metabotropiske modulatorer av glutamatreseptorer | |
| NO20083562L (no) | Cannabinoidreseptormodulatorer | |
| NO20065847L (no) | Difenylimidazopyrimidiner og -imidazolaminer som inhibitorer av B-sekretase | |
| NO20071343L (no) | Substituerte fenylaminotiazoler og anvendelse derav | |
| NO20074390L (no) | Forsterket bimatoprost oye-opplosning | |
| MA30201B1 (fr) | Derives triazoliques comme inhibiteurs de la 11-beta-hydroxysteroide dehydrogenase-1 | |
| NO20055680L (no) | Heksahydropyridoisokinoliner som DPP-IV-inhibitorer | |
| NO20083065L (no) | Nye N-sulfamoylpiperidinamider for profylakse eller behandling av overvekt og beslektede tilstander | |
| NO20070081L (no) | Sulfamat og sulfamidderivater for behandling av epilepsi og relaterte sykdommer | |
| NO20083036L (no) | Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon | |
| NO20073207L (no) | Aryl- og heteroaryl-substituerte tetrahydroisokinoliner og anvendelse derav til a blokkere gjenopptak av norepinefrin, dopamin og serotonin | |
| SE0403006D0 (sv) | New compounds | |
| EA200800081A1 (ru) | Бензамидные производные (варианты), содержащая их фармацевтическая композиция (варианты), способ лечения заболеваний, связанных с модуляцией гидроксистероиддегидрогеназ на основе указанных производных(варианты) | |
| RU2017139870A (ru) | Новые агонисты npr-b | |
| NO20065926L (no) | Substituerte oksazolbenzoisotiazoldioksidderivater samt fremgangsmate for fremstilling og anvendelse derav | |
| ATE539743T1 (de) | Verfahren zur prävention und behandlung von ppar- vermittelten zuständen mit macelignan | |
| NO20084865L (no) | Behandling av smertelidelser med trans 4-(3,4-diklorfenyl)-1, 2, 3,4-tetrahydro-1-nafthalenamin og dens formamid | |
| NO20062511L (no) | Fenoksy-eddiksyrederivater anvendelige som peroksisomproliferator-aktiverende reseptor (PPAR) dualagonister | |
| NO20063261L (no) | Selektive peroksisome proliferatoraktiviterte reseptormodulatorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |